Bringing the fundamentals into focus…
Back to Pacific Biosciences of California, Inc.
How Pacific Biosciences of California, Inc. stacks up
PACB · against 1,216 other Healthcare companies
Growth
44/ 100
Below the middle of the pack.
Ranked #676 of 1,217 · scores higher than 44% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 40–49, including PACB · Click a bar to see the companies
Why growth scores 44?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- slower revenue growth over the last year: weaker than 64% of peers. Revenue growth: 2.0% vs peer median 6.1%
- slower revenue growth over three years: weaker than 62% of peers. 3-year revenue growth: 2.9% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = PACB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PACB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 2.0% | 6.1% | 36% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 2.9% | 5.8% | 38% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around PACB| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 676 | 84.5B EUR (≈$92.9B) | 44 | 51 | |
| 676 | 63.7B INR (≈$764M) | 44 | 66 | |
| 676 | 436.2B INR (≈$5.2B) | 44 | ||
| 676 | 862M AUD (≈$569M) | 44 | 54 | |
| 676 | 758M USD | 44 | 35 | |
| 676 | 272.9B BRL (≈$49.1B) | 44 | 43 | |
| 676 | 258.2B USD | 44 | 47 | |
| 689 | 99.2B CNY (≈$13.9B) | 43 | 67 | |
| 689 | 13.3B CNY (≈$1.9B) | 43 | 73 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score